Unknown

Dataset Information

0

The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats.


ABSTRACT: GABAergic signaling is involved in modulating the reinforcing properties of alcohol, and GABAB receptors have been proposed as a potential target for clinical treatment of alcoholism. The orthosteric GABAB receptor agonist baclofen has been shown to suppress operant self-administration of alcohol in animals and alcohol use in alcohol-dependent patients, but its utility is limited by a narrow therapeutic index. We tested the effects of ADX71441, a novel GABAB receptor positive allosteric modulator, on alcohol-related behaviors in rats. We first assessed the effects of ADX71441 (1, 3, 10 and 30?mg/kg, I.P.) on both non-dependent and dependent male Wistar rats trained to self-administer 20% alcohol. We then determined the effects of ADX71441 on stress-induced as well as cue-induced relapse-like behavior. Finally, we sought to identify the brain regions through which ADX71441 may act to prevent relapse-like behavior by mapping the neuronal activation induced by stress-induced reinstatement of alcohol-seeking using c-Fos immunohistochemistry. ADX71441 dose-dependently decreased alcohol self-administration of both dependent and non-dependent animals, but its potency was higher in alcohol-dependent rats. Furthermore, both cue- and stress-induced alcohol seeking were blocked by the GABAB receptor positive allosteric modulator. Finally, pretreatment with 3?mg/kg of ADX71441 before stress-induced reinstatement significantly decreased c-Fos expression in a network of brain regions implicated in stress-induced relapse, comprising the nucleus accumbens shell, the dorsal raphe nucleus and the medial prefrontal cortex. Our findings support a causal role of GABAB receptors in alcohol reinforcement and relapse to alcohol seeking. These effects are observed in the absence of significant sedative side effects. Jointly, these observations indicate that GABAB receptor positive allosteric modulators merit being tested clinically for the treatment of alcoholism. Our data also point to a potential biomarker of target engagement for early clinical studies.

SUBMITTER: Augier E 

PROVIDER: S-EPMC5520784 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

The GABA<sub>B</sub> Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats.

Augier Eric E   Dulman Russell S RS   Damadzic Ruslan R   Pilling Andrew A   Hamilton J Paul JP   Heilig Markus M  

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20170315 9


GABAergic signaling is involved in modulating the reinforcing properties of alcohol, and GABA<sub>B</sub> receptors have been proposed as a potential target for clinical treatment of alcoholism. The orthosteric GABA<sub>B</sub> receptor agonist baclofen has been shown to suppress operant self-administration of alcohol in animals and alcohol use in alcohol-dependent patients, but its utility is limited by a narrow therapeutic index. We tested the effects of ADX71441, a novel GABA<sub>B</sub> rece  ...[more]

Similar Datasets

| S-EPMC8585307 | biostudies-literature
| S-EPMC5061885 | biostudies-other
| S-EPMC10354045 | biostudies-literature
| S-EPMC7014573 | biostudies-literature
| S-EPMC4748423 | biostudies-literature
| S-EPMC5118774 | biostudies-literature
| S-EPMC5183547 | biostudies-literature
| S-EPMC4915260 | biostudies-literature
| S-EPMC7914186 | biostudies-literature
| S-EPMC2922422 | biostudies-literature